Retrospective Assessment of the Treatment of Sporotrichosis in Cats and Dogs Using Itraconazole
|
|
- Anna Gallagher
- 6 years ago
- Views:
Transcription
1 Acta Scientiae Veterinariae, : RESEARCH ARTICLE Pub ISSN Retrospective Assessment of the Treatment of Sporotrichosis in Cats and Dogs Using Itraconazole Claudio Nazaretian Rossi, Juliana Odaguiri & Carlos Eduardo Larsson ABSTRACT Background: Cases of sporotrichosis in male and female cats and dogs of different ages with cutaneous sporotrichosis that were treated at the dermatology service of a teaching veterinary hospital and orally administered itraconazole (ITC) were retrospectively characterized by reviewing the clinical records corresponding to a 19-year period ( ). The aim of the present study was to analyze regarding clinical cure, side effects, length of treatment and relapse using ITC in the treatment of cutaneous sporotrichosis in cats and dogs. Materials, Methods & Results: From the assessed case series, 20 animals were selected, of which 17 (85.0%) were cats and three (15.0%) were dogs; the animals were mostly males (80.0%) and of ill-defined breeds (75.0%). Cases of sporotrichosis in male and female cats and dogs of different ages that were treated at the dermatology service of a teaching veterinary hospital and orally administered ITC (10 mg/kg) once a day. The percentage of full remission of the treated cases, regardless of their clinical form, was 100%, and no systemic or tegumentary side effects were found in the assessed animals. The average duration of treatment was 3.4 months in cats and 11.3 months in dogs, whereas the maximum duration of treatment required to resolve the clinical condition in the assessed case series of cats and dogs was 16 months, regardless of the animal species. Relapses occurred in 15.0% (one cat and two dogs) of the cases treated with the investigated antifungal agent. Discussion: The remarkable difference in the average duration of therapy required to achieve clinical cure between cats and dogs might be related to the fact that most of the cases of feline sporotrichosis were of the localized cutaneous form (82.3%). Conversely, the three cases of canine sporotrichosis were of the disseminated cutaneous form, which may have delayed the success of treatment. Clinically manifested systemic or tegumentary side effects were not reported by the pet owners or were detected by clinical examination of the animals that were subjected to treatment with ITC in the present study, which agrees with previous reports. However, given the retrospective character of this research complementary laboratory exams are lacking and thus it cannot be asserted that alterations do not exist. Therapeutic failure was not observed with the use of ITC in the investigated cases of canine and feline sporotrichosis. Clinical relapse occurred in two dogs and one cat, all of which exhibited the disseminated cutaneous form, which might have predisposed them to clinical recrudescence. In addition, the evident difference in the percentage of relapse between the two species might be correlated with the higher prevalence of the disseminated cutaneous form among the investigated dogs (100%) compared with the cats (40%). Of the animals that exhibited relapse, one dog had been treated with topical corticoids for the previous three months. According to the literature, glucocorticoids and other immunosuppressants are contraindicated in dogs and cats with sporotrichosis. The cat, in turn, exhibited respiratory disease complex in addition to sporotrichosis, which might be related to the clinical relapse. In conclusion, ITC is efficacious in the treatment of sporotrichosis in cats and dogs and does not induce apparent side effects. Keywords: sporotrichosis, mycosis, treatment, itraconazole, dog, cat. Received: 30 May 2012 Accepted: 11 September 2012 Published: 23 January 2013 Serviço de Dermatologia do Departamento de Clínica Médica da Faculdade de Medicina Veterinária e Zootecnia da Universidade de São Paulo (FMVZ- USP), São Paulo, SP, Brazil. CORRESPONDENCE: C.E. Larsson [larsderm@hotmail.com - Fax: +55 (11) ]. Departamento de Clínica Médica (VCM), Faculdade de Medicina Veterinária e Zootecnia da Universidade de São Paulo (FMVZ-USP), Av. Prof. Dr. Orlando Marques de Paiva n. 87, Butantã. CEP São Paulo, SP, Brazil. 1
2 INTRODUCTION Sporotrichosis is a mycotic disease that is caused by the dimorphic fungus of the Sporothrix schenkii complex [8] and can affect humans, dogs and cats, among other species [4]. The typical protocol for the treatment of classic animal sporotrichosis is based on the protocol used in the treatment of humans and includes halogens (20% potassium or sodium iodide in saturated solution) that are orally administered [5,6]. Other therapeutic options for cats and dogs with sporotrichosis include azoles (ketoconazole, fluconazole), imidazoles (itraconazole), allylamines (terbinafine), polyenic drugs (amphotericin B), cryotherapy and surgical resection of the skin lesions [11]. The ITC is currently considered the drug of choice for the treatment of sporotrichosis in cats because of its higher effectiveness and safety compared with other antifungal drugs [5,10,11,17]. The main side effects reported to be caused by ITC treatment in dogs and cats include dysorexia, emesis and diarrhea, and in addition an increase in the serum levels of the liver enzymes [12-14,17]. As disadvantages of this protocol, the literature mentions the need for longer treatment, per two to six or more months [13] and its high cost [16]. Regardless of the drug chosen, pharmacological treatment must be continued for at least one month after apparent clinical remission to prevent the relapse of clinical manifestations [12,17]. The aim of the present study was to survey the clinical experience associated with the use of ITC for the treatment of cutaneous sporotrichosis in cats and dogs regarding clinical cure, side effects, length of treatment and relapse. MATERIALS AND METHODS Clinical cases with an established diagnosis of sporotrichosis in cats and dogs that were assisted at a Dermatology Service (DS) were retrospectively reviewed from 1993, the year when the protocol for ITC treatment was pioneeringly instituted for the treatment of sporotrichosis, to September From these records, the animals with a confirmed diagnosis that were treated with ITC were selected. Cats and dogs of any age and gender with a diagnosis of sporotrichosis that was confirmed by fungal culture, direct microscopic examination and/ or histopathological exam, that were treated with ITC and consistently followed up at the DS were included in the present study. Animals that were not treated with ITC, those whose owners who did not perform the treatment in an appropriate manner, or those with an inappropriately assessed clinical evolution were excluded. The clinical presentation of sporotrichosis was classified either as localized or disseminated cutaneous or as lymphocutaneous. The data were entered in a spreadsheet and grouped according to species, breed, age, detected side effects and clinical relapse. In all of the cases, the treatment included ITC Sporanox (oral capsules 100 mg) 1, at 10 mg/kg orally every 24 h together with food for up to four weeks after the clinical remission of lesions. The animals were considered cured if they did not relapse within one year after clinical discharge. In contrast, the animals were considered re-infected if, following an initial period of apparent clinical cure, they exhibited new lesions up to one year from the end of treatment. The treatment was considered incomplete if the medication was discontinued before achieving full remission of the clinical manifestations or if it was not continued for at least one month after the regression of the lesions. RESULTS Out of a total of 37 cases (nine dogs and 28 cats) of sporotrichosis identified in the 19-year investigated period, 17 (45.9%) were excluded because they did not meet all of the inclusion criteria (the animal did not return for follow up, or the owner did not perform the treatment in an appropriate manner) or a treatment protocol other than ITC was instituted. The final sample included 17 cats and three dogs. Regarding breeds, three (17.6%) of the 17 cats had a well-defined breed (WDB), all of which were Siamese, and 14 (82.4%) had an ill-defined breed (IDB). Of the dogs, two (66.7%) had IDB, and one (33.3%) was a boxer. The average age of the cats was 38.4 months old, varying between three and 108 months of age, and the average age of the dogs was 80 months old, varying between 72 and 84 months of age. Regarding gender, most of the cats ( %) and all three dogs were male. The data also showed that 12 (70.6%) cats exhibited the localized cutaneous form, whereas the remainder (five) of the cats and all three dogs exhibited the disseminated cutaneous form. 2
3 Regarding the therapeutic response, all 20 (100%) animals treated with ITC that were included in the present study progressed into clinical cure (Figures 1-4). The average time to achieve clinical cure was 3.4 months for cats and 11.3 months for dogs. No side effects and/or therapeutic failures were observed in any of the animals subjected to treatment with ITC. Clinical relapse was observed in three animals with the disseminated cutaneous form of disease. Two (66.7%) of the relapsing animals were dogs, one of which had been treated with topical corticoids for three months before relapse, and one (5.9%) was a cat, which exhibited respiratory disease complex as a comorbidity. Figure 1. Cat with sporotrichosis before treatment presenting crusts and ulcers in the head. Figure 2. The same cat about 45 days after the diagnosis of sporotrichosis and institution of therapy with itraconazole. Figure 3. Dog with sporotrichosis before treatment presenting erosive areas, erythema and hyperplasia of nostrils and lips. DISCUSSION The success found by the present study regarding the treatment of animals with sporotrichosis using ITC corroborates a report by Crothers et al. [1], who found 88.9% and 100% clinical improvement in dogs and cats, respectively, and a study reported by Schubach et al. [15] in dogs. However, these results disagree with those reported by other authors, who found lower rates of efficacy (38.3% Figure 4. The same dog about 60 days after the diagnosis of sporotrichosis and institution of therapy with itraconazole. and 50.0%, respectively) with this same treatment in cats [7,10]. Such differences may have been due to the different degree of severity of the clinical forms of disease among the studies (the localized or disseminated and the systemic forms) or to the lack of compliance with treatment by the pet owners, which may result in therapeutic failure. In addition, certain reports in the literature indicate that the localized cutaneous form 3
4 (initial chancre) has a better prognosis compared with the disseminated form [3]. The remarkable difference in the average duration of therapy required to achieve clinical cure between cats and dogs might be related to the fact that most of the cases of feline sporotrichosis were of the localized cutaneous form (82.3%). Conversely, the three cases of canine sporotrichosis were of the disseminated cutaneous form, which may have delayed the success of treatment. Pereira et al. [10] reported an average time to clinical cure of 5.5 months in cats treated with ITC, whereas in the dogs studied by Schubach et al. [15], an average of 2.5 months since the onset of treatment was observed. Clinically manifested systemic or tegumentary side effects did not occur in any of the animals that were subjected to treatment with ITC, which agrees with previous reports [2,17]. Several authors have warned against or even observed adverse effects affecting the digestive system, with nausea, dysorexia, emesis and gastrointestinal pain [11,14,17] or the integumentary systems, mainly hair hypopigmentation [10,16]; however, none of these effects were reported by the pet owners in the present study. Neither were clinical manifestations compatible with the liver damage reported. However, the serum levels of the liver enzymes were not measured or followed up in all of the cases treated with ITC; therefore, it cannot be asserted that these levels were not altered. Therapeutic failure was not observed with the use of ITC in the investigated cases of canine and feline sporotrichosis. Clinical relapse occurred in two dogs and one cat, all of which exhibited the disseminated cutaneous form, which might have predisposed them to clinical recrudescence. In addition, the evident difference in the percentage of relapse between the two species might be correlated with the higher prevalence of the disseminated cutaneous form among the investigated dogs (100%) compared with the cats (40%). Moreover, according to the literature, the response of dogs is quite variable, and relapse is not infrequent [9]. The average times for relapse to occur were 67.5 and 10 days in the dogs and the cat, respectively. Of the animals that exhibited relapse, one dog had been treated with topical corticoids for the previous three months. According to the literature, glucocorticoids and other immunosuppressants, such as cyclosporine, are contraindicated in dogs and cats with sporotrichosis, and these medications must also be avoided after treatment because immunosuppressing doses of glucocorticoids have been correlated with sporotrichosis relapse even four to six months after apparent clinical cure [12,16]. The cat, in turn, exhibited respiratory disease complex in addition to sporotrichosis, which might be related to the clinical relapse. CONCLUSION Based on the results described above in regard to the therapeutic response, ITC was efficacious in the treatment of sporotrichosis in cats and dogs without inducing apparent side effects. SOURCE AND MANUFACTURER 1 Itraconazole, Janssen-Cilag Farmacêutica Ltda, São Paulo, SP, Brazil. Declaration of interest. The authors report no conflicts of interest. The authors alone are responsible for the content and writing of the paper. REFERENCES 1 Crothers S.L., White S.D., Ihrke O.J. & Affoltert V.K Sporotrichosis: a retrospective evaluation of 23 cases seen in northen California ( ). Veterinary Dermatology. 20(4): Gross T.L., Ihrke P.J., Walder E.J. & Affolter V.K Infectious nodular and diffuse diseases of the dermis. In: Skin diseases of the dog and cat - clinical and histopathologic diagnosis. 2nd edn. Oxford: Blackwell Science, pp Hennemann C.R.A., Guimarães J. & Bremm M Esporotricose felina: uma revisão. Veterinária em Foco. 1: Irizarry-Rovira A.R., Kaufman L., Christian J.Á., Reberg S.R., Adams S.B., DeNicola D.B., Rivers W. & Hawkins J.F Diagnosis of sporotrichosis in a donkey using direct fluorescein-labeled antibody testing. Journal of Veterinary Diagnostic Investigation. 12: Kauffman C.A., Bustamante B., Chapman S.W. & Pappas P.G Clinical practice guidelines for the management of sporotrichosis: 2007 update by the Infectious Diseases Society of America. Clinical Infectious Diseases. 45(10): Larsson C.E Micoses profundas. In: Anales del 20 Congreso Panamericano de Ciencias Veterinarias (Santiago, Chile). pp
5 7 Madrid M.I., Mattei A., Martins A., Nobre M. & Meireles M Feline sporotrichosis in the southern region of Rio Grande do Sul, Brazil: clinical, zoonotic and therapeutic aspects. Zoonoses Public Health. 57: Marimon R., Cano J., Gené J., Sutton D.A., Kawasaki M. & Guarro J Sporothrix brasiliensis, S. globosa, and S. mexicana, three new Sporothrix species of clinical interest. Journal of Clinical Microbiology. 45(3): Medleau L. & Hlinica K.A Doenças nodulares. In: Dermatologia de pequenos animais - atlas colorido e guia terapêutico. São Paulo: Roca, pp Pereira S.A., Passos S.R.L., Silva J.N., Gremião I.D.F., Figueiredo F.B., Teixeira J.L., Monteiro P.C. & Schubach T.M.P Response to azolic antifungal agents for treating feline sporotrichosis. Veterinary Record. 166: Pereira S.A., Schubach T.M.P., Gremião I.D.F., Silva D.T., Figueiredo F.B., Assis N.V. & Passos S.R.L Aspectos terapêuticos da esporotricose felina. Acta Scientiae Veterinariae. 37(4): Rosser E.J. & Dunstan R.W Sporotrichosis. In: Greene C.E. (Ed). Infectious diseases of the dog and cat. 4th edn. Philadelphia: W.B. Saunders Company, pp Schubach T.M.P., Menezes R.C. & Wanke B Sporotrichosis. In: Greene C.E. (Ed). Infectious diseases of the dog and cat. 4th edn. Philadelphia: W.B. Saunders Company, pp Schubach T.M.P., Schubach A., Okamoto T., Barros M.B., Figueiredo F.B., Cuzzi T., Fialho-Monteiro P.C., Reis R.S., Perez M.A. & Wanke B Evaluation of an epidemic of sporotrichosis in cats: 347 cases ( ). Journal of the American Veterinary Medical Association. 224(10): Schubach T.M.P., Schubach A., Okamoto T., Barros B.L., Figueiredo F.B., Cuzzi T., Pereira S.A., Dos Santos I.B., Paes R.A., Leme L.R.P. & Wanke B Canine sporotrichosis in Rio de Janeiro, Brazil: clinical presentation, laboratory diagnosis and therapeutic response in 44 cases ( ). Medical Mycology. 44(1): Scott D.W., Miller Jr. W.H. & Griffin C.E Fungal skin diseases. In: Muller & Kirk s Small Animal Dermatology. Philadelphia: W.B. Saunders Company, pp Welsh R.D Sporotrichosis. Journal of the American Veterinary Medical Association. 223(8):
Miltefosine Administration in Cats with Refractory Sporotrichosis
Acta Scientiae Veterinariae, 2018. 46: 1571. RESEARCH ARTICLE Pub. 1571 ISSN 16799216 Miltefosine Administration in Cats with Refractory Sporotrichosis Francine dos Santos da Silva, Simone Carvalho dos
More informationProceedings of the 34th World Small Animal Veterinary Congress WSAVA 2009
www.ivis.org Proceedings of the 34th World Small Animal Veterinary Congress WSAVA 2009 São Paulo, Brazil - 2009 Next WSAVA Congress : Reprinted in IVIS with the permission of the Congress Organizers DERMATOZOONOSIS
More informationAssociation of itraconazole and potassium iodide in the treatment of feline sporotrichosis: a prospective study
Medical Mycology, 2016, 54, 684 690 doi: 10.1093/mmy/myw027 Advance Access Publication Date: 20 May 2016 Original Article Original Article Association of itraconazole and potassium iodide in the treatment
More informationDERMATOPHYTOSIS IN CATS AND DOGS: SIGNS AND MANAGEMENT
Vet Times The website for the veterinary profession https://www.vettimes.co.uk DERMATOPHYTOSIS IN CATS AND DOGS: SIGNS AND MANAGEMENT Author : Filippo De Bellis Categories : Vets Date : June 20, 2011 Filippo
More informationMacêdo-Sales et al. BMC Veterinary Research (2018) 14:19 DOI /s
Macêdo-Sales et al. BMC Veterinary Research (2018) 14:19 DOI 10.1186/s12917-018-1340-4 RESEARCH ARTICLE Open Access Domestic feline contribution in the transmission of Sporothrix in Rio de Janeiro State,
More informationFungal Disease. What is a fungus?
Fungal Disease What is a fungus? A fungus is a living organism. It goes through a complicated life cycle and is able to spread in the environment by producing large numbers of spores that are easily dispersed
More informationClinical Policy: Itraconazole (Sporanox) Reference Number: CP.PPA.07. Line of Business: Medicaid
Clinical Policy: (Sporanox) Reference Number: CP.PPA.07 Effective Date: 11/06 Last Review Date: 05/17 Line of Business: Medicaid Coding Implications Revision Log See Important Reminder at the end of this
More informationParasitic and Fungal Skin Diseases of Dog and Cats - Review on Pathophysiology, Diagnosis and Treatment
Parasitic and Fungal Skin Diseases of Dog and Cats - Review on Pathophysiology, Diagnosis and Treatment Dr. S. Yogeshpriya 1, Dr. P. Selvaraj and Dr. B. Puvarajan 2 1 Assistant Department of Veterinary
More informationSporotrichosis cat as the source of familiar infection outbreak in Guarulhos, São Paulo: a case report
439 CASE REPORT Sporotrichosis cat as the source of familiar infection outbreak in Guarulhos, São Paulo: a case report Esporotricose gato como fonte de infecção em foco epidêmico familiar em Guarulhos,
More informationProceedings of the Southern European Veterinary Conference - SEVC -
www.ivis.org Proceedings of the Southern European Veterinary Conference - SEVC - Sep. 29-Oct. 2, 2011, Barcelona, Spain Next SEVC Conference: Oct. 18-21, 2012 - Barcelona, Spain Reprinted in the IVIS website
More informationJournal of Advanced Veterinary Research. Original Research. Volume 4, Issue 3 (2014)
Journal of Advanced Veterinary Research Volume 4, Issue 3 (2014) 108-112 Original Research Efficacy of Enrofloxacin in the Treatment of Recurrent Pyoderma in Dogs B. Sudhakara Reddy 1 *, K. Nalini Kumari
More informationIndian Journal of Canine Practice Volume 6 Issue 2, December, 2014
THERAPEUTIC TRIALS OF PYODERMA IN DOGS WITH CLINDAMYCIN AND IN COMBINATION WITH A TOPICAL ANTIBACTERIAL COMBINATION OF CHLORHEXIDINE GLUCONATE AND SILVER SULPHADIAZENE M.A. Kshama¹ and S.Yathiraj² ¹Assistant
More informationVeterinary Microbiology ( ) Systemic mycoses 1 Dimorphic fungi รศ.สพ.ญ.อรวรรณ นว ภาพ ภาคว ชาจ ลช วว ทยา คณะส ตวแพทยศาสตร จ ฬาลงกรณ มหาว ทยาล ย
Veterinary Microbiology (3110301) Systemic mycoses 1 Dimorphic fungi รศ.สพ.ญ.อรวรรณ นว ภาพ ภาคว ชาจ ลช วว ทยา คณะส ตวแพทยศาสตร จ ฬาลงกรณ มหาว ทยาล ย 2547 Systemic mycoses แบ งเป น 3 group 1. เก ดจาก true
More informationComparison of Efficacy, Side Effects, and Cost of Isoxasolines and Ivermectin Against Generalized Canine Demodicosis
Comparison of Efficacy, Side Effects, and Cost of Isoxasolines and Ivermectin Against Generalized Canine Demodicosis Item Type text; Electronic Thesis Authors Leinart, Linzey Barbara Publisher The University
More informationMycology II. Cutaneous and Subcutaneous Mycoses. Cutaneous Mycoses: Dermatophytoses
Mycology II Cutaneous and Subcutaneous Mycoses Cutaneous Mycoses: Dermatophytoses Ringworm zoonotic describes clinical appearance Trichophyton /Microsporum Skin, hair, nails - dermis. No systemic disease
More informationNew Insights into the Treatment of Leishmaniasis
New Insights into the Treatment of Leishmaniasis Eric Zini Snow meeting, 14 March 2009 Few drugs available for dogs Initially developed to treat human leishmaniasis, later adopted in dogs None eradicates
More informationThe Current Status of Feline Sporotrichosis in Malaysia
Med. Mycol. J. Vol. Med. 58E, Mycol. E 107 J. Vol. E 113, 58(No. 2017 3), 2017 E 107 ISSN 2185 6486 Review The Current Status of Feline Sporotrichosis in Malaysia Han Hock Siew Former Han Veterinary Surgery
More informationBlastomycosis is a frequently diagnosed systemic
J Vet Intern Med 2014 Serum and Urine Blastomyces Antigen Concentrations as Markers of Clinical Remission in Dogs Treated for Systemic Blastomycosis D.S. Foy, L.A. Trepanier, E.J. Kirsch, and L.J. Wheat
More informationFeline allergic dermatitis: clinical aspects and diagnosis
Zurich Open Repository and Archive University of Zurich Main Library Strickhofstrasse 39 CH-8057 Zurich www.zora.uzh.ch Year: 2013 Feline allergic dermatitis: clinical aspects and diagnosis Favrot, C Posted
More informationCutaneous and Subcutaneous Mycoses
Cutaneous and Subcutaneous Mycoses Cutaneous Mycoses: Dermatophytoses Ringworm zoonotic describes clinical appearance Microsporum + Trichophyton Skin, hair, nails - dermis. No systemic disease Infections
More informationActa Scientiae Veterinariae ISSN: Universidade Federal do Rio Grande do Sul Brasil
Acta Scientiae Veterinariae ISSN: 1678-0345 ActaSciVet@ufrgs.br Universidade Federal do Rio Grande do Sul Brasil Rodrigues Ferreira, Rafael; Ferreiro, Laerte; Spanamberg, Andréia; Driemeier, David; da
More informationCoccidioidomycosis Nothing to disclose
Coccidioidomycosis Nothing to disclose Disclosure Greg Melcher, M.D. Professor of Clinical Medicine Division of HIV, ID and Global Medicine Zuckerman San Francisco General Hospital University of California,
More informationThe Runny Nose That Isn t Just a Cold
The Runny Nose That Isn t Just a Cold By Susan Chaney Posted in: Canine Health, Learn!, Right Now! No comments Aspergillus spores are everywhere in the soil, in plant material, even in dust. We breathe
More informationHudson, a 10-year-old MC Cocker spaniel, was referred for evaluation of severe polyuria and polydipsia (PU/PD) of 3 months in duration...
VCAWLAspecialty.com David Bruyette, DVM, DACVIM Hudson, a 10-year-old MC Cocker spaniel, was referred for evaluation of severe polyuria and polydipsia (PU/PD) of 3 months in duration... 1. Physical Examination
More informationEPAR type II variation for Metacam
23 June 2011 EMA/674662/2011 International Non-proprietary Name: Meloxicam Procedure No. EMEA/V/C/033/II/084 EU/2/97/004/026, 33-34 Scope: Type II Addition of indication for cats Page 1/6 Table of contents
More informationAUSTRALIAN AND NEW ZEALAND COLLEGE OF VETERINARY SCIENTISTS MEMBERSHIP GUIDELINES. Veterinary Pathology (includes Anatomical and Clinical Pathology)
2017 AUSTRALIAN AND NEW ZEALAND COLLEGE OF VETERINARY SCIENTISTS MEMBERSHIP GUIDELINES Veterinary Pathology (includes Anatomical and Clinical Pathology) ELIGIBILITY REQUIREMENTS OF CANDIDATE The candidate
More informationFungal Dermatitis in a central bearded dragon
Vet Times The website for the veterinary profession https://www.vettimes.co.uk Fungal Dermatitis in a central bearded dragon Author : PRU HARVEY Categories : Vets Date : April 14, 2014 Summary A central
More informationParasites Infections Allergy Pemphigus Acne Indolent ulcer Neck ulcers. Flea Allergy Dermatitis Cheyletiella. Contagious demodicosis in a shelter
Douglas J. DeBoer, D.V.M., Diplomate A.C.V.D. School of Veterinary Medicine University of Wisconsin-Madison Parasites Infections Allergy Pemphigus Acne Indolent ulcer Neck ulcers Flea Allergy Dermatitis
More informationSecond Opinion. Dermatology Service
Second Opinion Dermatology Service Dermatology/Allergy Clinic Veterinary Medical Teaching Hospital University of Wisconsin-Madison SECOND OPINION is an electronic service for referring veterinarians in
More informationANNEX I SUMMARY OF PRODUCT CHARACTERISTICS
ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Fungitraxx 10 mg/ml oral solution for ornamental birds 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each ml contains:
More informationThe CARI Guidelines Caring for Australians with Renal Impairment. 10. Treatment of peritoneal dialysis associated fungal peritonitis
10. Treatment of peritoneal dialysis associated fungal peritonitis Date written: February 2003 Final submission: July 2004 Guidelines (Include recommendations based on level I or II evidence) The use of
More informationSimplicef is Used to Treat Animals with Skin Infections
Simplicef is Used to Treat Animals with Skin Infections PRODUCT INFO Simplicef tablets are a semi-synthetic cephalosporin antibiotic cefpodoxime proxetil used to cure infections caused by the susceptible
More informationWork-up of alopecia. Favrot, C
Zurich Open Repository and Archive University of Zurich Main Library Strickhofstrasse 39 CH-8057 Zurich www.zora.uzh.ch Year: 2014 Work-up of alopecia Favrot, C Posted at the Zurich Open Repository and
More informationchoice The Rilexine Palatable Tablets First generation cephalosporin for skin infections Now registered for ONCE daily administration*
Virbac Dermatology Palatable Tablets The choice First generation cephalosporin for skin infections Now registered for ONCE daily administration* are only available under Veterinary Authorisation. www.virbac.co.nz
More informationFeline zoonoses. Institutional Animal Care and Use Committee 12/09
Feline zoonoses Institutional Animal Care and Use Committee 12/09 Cat scratch disease Bacterial infection caused by Bartonella henselae Associated with a cat bite or scratch Infection at point of injury,
More informationOtitis Externa: Pathogenesis, Treatment & Preventative Maintenance. All photos are copyright of CE Griffin, REW Halliwell, DN Carlotti & DH Lloyd
Otitis Externa: Pathogenesis, Treatment & Preventative Maintenance All photos are copyright of CE Griffin, REW Halliwell, DN Carlotti & DH Lloyd Anatomy Cartilage Ear canal Tympanum Otitis externa Inflammation
More informationLove your pets. And their skin.
Love your pets. And their skin. Find out how you can keep their skin looking and feeling healthy. Comfortable in their own skin. Pets have very different skin than people. FACT 1: A dog s skin is less
More informationReduce the risk of recurrence Clear bacterial infections fast and thoroughly
Reduce the risk of recurrence Clear bacterial infections fast and thoroughly Clearly advanced 140916_Print-Detailer_Englisch_V2_BAH-05-01-14-003_RZ.indd 1 23.09.14 16:59 In bacterial infections, bacteriological
More informationCanine juvenile cellulitis: a retrospective study ( )
407 Canine juvenile cellulitis: a retrospective study (2009-2016) Celulite juvenil canina: Estudo retrospectivo (2009-2016) José Artur Brilhante BEZERRA 1 ; Julianna Pereira da Silva SANTOS 2 ; Kilder
More informationPrevalence of Giardia in Household Dogs and Cats in the State of Rio de Janeiro using the IDEXX SNAP Giardia Test
Prevalence of Giardia in Household Dogs and Cats in the State of Rio de Janeiro using the IDEXX SNAP Giardia Test Norma Labarthe, MV, DSc 1 Flavya Mendes-de-Almeida, MV, DSc 1 Margareth Balbi, MV, MSc
More informationClinical Article DIAGNOSTIC AND THERAPEUTIC MANAGEMENT OF DEMODICID OTODECTIC MALASSEZIAL OTITIS EXTERNA IN A POODLE PUP
International Journal of Science, Environment and Technology, Vol. 5, No 5, 2016, 3115 3119 ISSN 2278-3687 (O) 2277-663X (P) Clinical Article DIAGNOSTIC AND THERAPEUTIC MANAGEMENT OF DEMODICID OTODECTIC
More informationInappropriate Use of Antibiotics and Clostridium difficile Infection. Jocelyn Srigley, MD, FRCPC November 1, 2012
Inappropriate Use of Antibiotics and Clostridium difficile Infection Jocelyn Srigley, MD, FRCPC November 1, 2012 Financial Disclosures } No conflicts of interest } The study was supported by a Hamilton
More informationOral and intestinal candidiasis. As adjuvant treatment with other local nystatin preparations to prevent reinfection.
1. NAME OF THE MEDICINAL PRODUCT Nystimex, 100 000 IU/ml oral suspension 2. QUALITATIVE AND QUANTITATIVE COMPOSITION 1 ml contains 100 000 IU nystatin. Excipients: Methyl parahydroxybenzoate 1 mg Sodium
More informationBacterial skin and soft tissues infections (SSTI) are one of the most common 1. infections among different age groups
Bacterial skin and soft tissues infections (SSTI) are one of the most common 1 infections among different age groups Gram-positive bacteria are the most frequently isolated pathogens from SSTI, with a
More informationCoccidioidomycosis in Dogs & Cats An Important Fungal Infection in Pets
Coccidioidomycosis in Dogs & Cats An Important Fungal Infection in Pets Infectious organisms are everywhere. Bacteria, viruses, and fungi threaten our pets every day. Some prefer specific environmental
More informationInfectious Diseases of Cattle, Buffaloes, Calves, Sheep and Goats
Infectious Diseases of Cattle, Buffaloes, Calves, Sheep and Goats Benha University Faculty of Veterinary Medicine Programme (s) on which the course is given: Bachelor of Veterinary Medical Sciences Department
More informationFatal poisoning in dogs and cats - A 6 - year report in a veterinary pathology service
304 Fatal poisoning in dogs and cats - A 6 - year report in a veterinary pathology service Fabiana Galtarossa XAVIER 1 Dario Abbud RIGHI 1 Helenice de Souza SPINOSA 1 Corresponding author: Departamento
More informationClinical Programme. Dermatology
2018 The diagnosis and management of skin represents a major component of small animal practice. Through lectures, case discussions and practical sessions, this modular programme will enable you to learn
More informationGUIDELINES FOR THE MANAGEMENT OF COMMUNITY-ACQUIRED PNEUMONIA IN ADULTS
Version 3.1 GUIDELINES FOR THE MANAGEMENT OF COMMUNITY-ACQUIRED PNEUMONIA IN ADULTS Date ratified June 2008 Updated March 2009 Review date June 2010 Ratified by Authors Consultation Evidence base Changes
More informationVeterinary Medicine - VMED
Veterinary Medicine - VMED 1 Veterinary Medicine - VMED Courses VMED 7230 CUTANEOUS DISORDERS OF LARGE AND EXOTIC ANIMALS (3) LEC. 3, IND/LEC. 9-12. In depth review of the common and uncommon dermatologic
More informationCanine Distemper Virus
Photo: LE Carmichael, MJ Appel Photo: LE Carmichael, MJ Appel Photo: LE Carmichael, MJ Appel Canine Distemper Virus Canine Distemper (CD) is a highly contagious infectious disease of dogs worldwide caused
More informationLINEE GUIDA: VALORI E LIMITI
Ferrara 28 novembre 2014 LINEE GUIDA: VALORI E LIMITI Pierluigi Viale Clinica di Malattie Infettive Policlinico S. Orsola Malpighi EVIDENCE BIASED GERIATRIC MEDICINE Older patients with comorbid conditions
More informationDuke University Hospital Guideline for Empiric Inpatient Treatment of Cancer- Related Neutropenic Fever in Adult Patients
Duke University Hospital Guideline for Empiric Inpatient Treatment of Cancer- Related Neutropenic Fever in Adult Patients PURPOSE Fever among neutropenic patients is common and a significant cause of morbidity
More informationTHE ROYAL COLLEGE OF VETERINARY SURGEONS DIPLOMA EXAMINATION IN VETERINARY DERMATOLOGY. Tuesday 22 August PAPER 1 (3 hours)
DIPLOMA EXAMINATION IN VETERINARY DERMATOLOGY Tuesday 22 August 2000 PAPER 1 Candidates are required to answer FOUR questions only. 1. What is meant by the term staphylococcal virulence factors. Indicate
More informationTreating Multi-animal Facilities Infected with Dermatophytosis
Treating Multi-animal Facilities Infected with Dermatophytosis By Dr. Keith A. Hnilica, DVM, MS, DACVD University of Tennessee Treating dermatophytosis can be a frustrating endeavor especially in multi-animal
More informationLyme disease: diagnosis and management
National Institute for Health and Care Excellence Final Lyme disease: diagnosis and management [D] Evidence review for the management of erythema migrans NICE guideline 95 Evidence review April 2018 Final
More informationOral and intestinal candidiasis. As adjuvant treatment with other local nystatin preparations to prevent reinfection.
1. NAME OF THE MEDICINAL PRODUCT Nystatin Orifarm, 100 000 IU/ml oral suspension 2. QUALITATIVE AND QUANTITATIVE COMPOSITION 1 ml contains 100 000 IU nystatin. Excipients with known effect: - Methyl parahydroxybenzoate
More informationAuthor - Dr. Josie Traub-Dargatz
Author - Dr. Josie Traub-Dargatz Dr. Josie Traub-Dargatz is a professor of equine medicine at Colorado State University (CSU) College of Veterinary Medicine and Biomedical Sciences. She began her veterinary
More informationTaking the Guess Out of Fungus: Dermatophytosis
Taking the Guess Out of Fungus: Dermatophytosis Aleisha Swartz, DVM Hawaiian Humane Society, HSUS University of Wisconsin Fellow Jyothi V. Robertson, DVM JVR Shelter Strategies & UC-Davis KSMP Resident
More information4-year-old neutered male American domestic shorthair cat with a locally extensive area of swelling ulceration and crusting over the nasal planum.
4-year-old neutered male American domestic shorthair cat with a locally extensive area of swelling ulceration and crusting over the nasal planum. Which of the following is the most likely disease? 1. Squamous
More informationUPDATE ON THE DIAGNOSIS AND MANAGEMENT OF DEMODICOSIS
UPDATE ON THE DIAGNOSIS AND MANAGEMENT OF DEMODICOSIS James O. xon, DVM, DACVIM Morrill Professor Department of Veterinary Clinical Sciences College of Veterinary Medicine Iowa State University Ames, IA
More informationB. PACKAGE LEAFLET 1
B. PACKAGE LEAFLET 1 PACKAGE LEAFLET NICILAN 400 mg/100 mg tablets for dogs 1. NAME AND ADDRESS OF THE MARKETING AUTHORISATION HOLDER AND OF THE MANUFACTURING AUTHORISATION HOLDER RESPONSIBLE FOR BATCH
More informationPREVALENCE OF CANINE BACTERIAL DERMATITIS IN WEST BENGAL
PREVALENCE OF CANINE BACTERIAL DERMATITIS IN WEST BENGAL Chandan Lodh and Surojit Das Department of Veterinary Medicine, Ethics and Jurisprudence. Faculty of Veterinary and Animal Sciences. West Bengal
More informationPeriod of study: 12 Nov 2002 to 08 Apr 2004 (first subject s first visit to last subject s last visit)
Study Synopsis This file is posted on the Bayer HealthCare Clinical Trials Registry and Results website and is provided for patients and healthcare professionals to increase the transparency of Bayer's
More informationOctodectes cynotis in cats and dogs diagnosis and management techniques
Vet Times The website for the veterinary profession https://www.vettimes.co.uk Octodectes cynotis in cats and dogs diagnosis and management techniques Author : Sue Paterson Categories : Clinical, RVNs
More informationI ve tried X, Y & Z Why is nothing working? Common Reasons for Dermatologic Treatment Failures. Charlie Pye BSc, DVM, DVSc, Diplomate ACVD
+ I ve tried X, Y & Z Why is nothing working? Common Reasons for Dermatologic Treatment Failures Charlie Pye BSc, DVM, DVSc, Diplomate ACVD + Overview Frustrating when treatment does not improve condition
More informationTreating Rosacea in the Era of Bacterial Resistance. This presentation is sponsored by Galderma Laboratories, L.P.
Treating Rosacea in the Era of Bacterial Resistance This presentation is sponsored by Galderma Laboratories, L.P. Lecture Discuss rosacea as an inflammatory condition Assess the psychosocial impact of
More informationSynopsis. Takeda Pharmaceutical Company Limited Name of the finished product UNISIA Combination Tablets LD, UNISIA Combination Tablets
Synopsis Name of the sponsor Takeda Pharmaceutical Company Limited Name of the finished product UNISIA Combination Tablets LD, UNISIA Combination Tablets Name of active ingredient Title of the study Study
More informationProceedings of the World Small Animal Veterinary Association Mexico City, Mexico 2005
Close this window to return to IVIS Proceedings of the World Small Animal Veterinary Association Mexico City, Mexico 2005 Hosted by: Reprinted in the IVIS website with the permission of the WSAVA Dermatolgy
More informationCOMMITTEE FOR VETERINARY MEDICINAL PRODUCTS
The European Agency for the Evaluation of Medicinal Products Veterinary Medicines and Inspections EMEA/CVMP/627/01-FINAL COMMITTEE FOR VETERINARY MEDICINAL PRODUCTS GUIDELINE FOR THE DEMONSTRATION OF EFFICACY
More informationAnimal Welfare Program of Chilean Dairy Consortiumsortiu. Danitza Abarzúa B. Animal welfare program coordinator
Animal Welfare Program of Chilean Dairy Consortiumsortiu Danitza Abarzúa B. Animal welfare program coordinator dabarzua@consorciolechero.cl Introduction Since 2012 animal welfare became a priority subject
More informationSUMMARY OF PRODUCT CHARACTERISTICS. Excipients: Contains 4% w/w cetyl alcohol and 7% w/w propylene glycol.
SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE MEDICINAL PRODUCT FLAMAZINE Cream 1 % w/w 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Contains Silver sulfadiazine 1 % w/w Excipients: Contains 4% w/w
More informationProphylactic antibiotic timing and dosage. Dr. Sanjeev Singh AIMS, Kochi
Prophylactic antibiotic timing and dosage Dr. Sanjeev Singh AIMS, Kochi Meaning - Webster Medical Definition of prophylaxis plural pro phy lax es \-ˈlak-ˌsēz\play : measures designed to preserve health
More informationDAYTON CHILDREN S HOSPITAL CLINICAL PRACTICE GUIDELINES
DAYTON CHILDREN S HOSPITAL CLINICAL PRACTICE GUIDELINES DISCLAIMER: This Clinical Practice Guideline (CPG) generally describes a recommended course of treatment for patients with the identified health
More informationEffects of Three Acepromazine Doses on the Incidence of Morphine-Induced Vomiting, Sedation and Some Physiological Variables in Dogs
Acta Scientiae Veterinariae, 2017. 45: 1504. RESEARCH ARTICLE Pub. 1504 ISSN 1679-9216 Effects of Three Acepromazine Doses on the Incidence of Morphine-Induced Vomiting, Sedation and Some Physiological
More informationOptimize Durations of Antimicrobial Therapy
Optimize Durations of Antimicrobial Therapy Evidence & Application Jill Cowper, Pharm.D. Division Infectious Diseases Pharmacist Parallon Supply Chain Solutions Richmond, VA P: 607 221 5101 jill.butterfield@parallon.com
More informationOptimizing Antibiotic Treatment of Skin and Soft Tissue Infections
Optimizing Antibiotic Treatment of Skin and Soft Tissue Infections 15th Annual Rocky Mountain Hospital Medicine Symposium November 6, 2017 Tim Jenkins, MD Director, Antibiotic Stewardship Program Denver
More informationThe Analysis of Computer Data regarding Obesity and Associated Diseases in Cats Examined at Private Veterinary Practices
Acta Scientiae Veterinariae, 2017. 45: 1506. RESEARCH ARTICLE Pub. 1506 ISSN 1679-9216 The Analysis of Computer Data regarding Obesity and Associated s in Cats Examined at Private Veterinary Practices
More informationClinical Manifestations and Treatment of Plague Dr. Jacky Chan. Associate Consultant Infectious Disease Centre, PMH
Clinical Manifestations and Treatment of Plague Dr. Jacky Chan Associate Consultant Infectious Disease Centre, PMH Update of plague outbreak situation in Madagascar A large outbreak since 1 Aug 2017 As
More informationSubmission for Reclassification
Submission for Reclassification Fucithalmic (Fusidic Acid 1% Eye Drops) From Prescription Medicine to Restricted Medicine (Pharmacist Only Medicine) CSL Biotherapies (NZ) Limited 666 Great South Road Penrose
More informationUSA Product Label CLINTABS TABLETS. Virbac. brand of clindamycin hydrochloride tablets. ANADA # , Approved by FDA DESCRIPTION
VIRBAC CORPORATION USA Product Label http://www.vetdepot.com P.O. BOX 162059, FORT WORTH, TX, 76161 Telephone: 817-831-5030 Order Desk: 800-338-3659 Fax: 817-831-8327 Website: www.virbacvet.com CLINTABS
More informationNaturally occurring hyperadrenocorticism is a wellrecognized
Evaluation of twice-daily lower-dose trilostane treatment administered orally in dogs with naturally occurring hyperadrenocorticism Edward C. Feldman, dvm, dacvim Objective To evaluate effectiveness and
More informationAmoxicillin Introduction: Mechanism of action: Pharmacology: Indications: Dosage: 12 Weeks ( 3 Months):
Amoxicillin Introduction: A semisynthetic antibiotic, an analog of ampicillin, with a broad spectrum of bactericidal activity against many gram-positive and gram-negative microganisms. Mechanism of action:
More informationGriseofulvin 500 mg microsize tablet Grifulvin V
MEDICATION COVERAGE POLICY PHARMACY AND THERAPEUTICS ADVISORY COMMITTEE POLICY Fungal Infections P&T DATE 12/14/2016 THERAPEUTIC CLASS Infectious Diseases REVIEW HISTORY 5/15, 9/13, 6/08 LOB AFFECTED MediCal,
More informationB. PACKAGE LEAFLET 1
B. PACKAGE LEAFLET 1 PACKAGE LEAFLET FOR: Cadorex 300 mg/ml solution for injection for cattle, sheep and pigs 1. NAME AND ADDRESS OF THE MARKETING AUTHORISATION HOLDER AND OF THE MANUFACTURING AUTHORISATION
More informationJust where it s needed.
Relief. Just where it s needed. Tissue-selective 7,8 Strong safety profile 5,6,10,11 For dogs and cats Onsior is available in a range of convenient and easy-to-dose formulations. Injectable solution for
More informationDiagnosis of Leptospira spp. Infection in Sheep Flocks in the State of Mato Grosso, Brazil
Acta Scientiae Veterinariae, 2017. 45: 1499. RESEARCH ARTICLE Pub. 1499 ISSN 1679-9216 Diagnosis of Leptospira spp. Infection in Sheep Flocks in the State of Mato Grosso, Brazil Camila Eckstein 1, Luciano
More information1/9/16% Sponsorship. Introduc.on% Garret%Pach.nger,%VMD,% DACVECC% COO,%VETgirl%
Sponsorship Introduc.on% Garret%Pach.nger,%VMD,% DACVECC% COO,%VETgirl% 1% Introduction Jus.ne%A.%Lee,%DVM,% DACVECC,%DABT% CEO,%VETgirl% Conflict of Interest Disclosure VETgirl On-The-Run! The tech-savvy
More informationThe use of a spot-on composed of polyunsaturated fatty acids and essential oils for treating kerato-seborrheic disorders: open study
The use of a spot-on composed of polyunsaturated fatty acids and essential oils for treating kerato-seborrheic disorders: open study By A. Jamoteau and E. Bensignor Summary Kerato-sebrorrheic disorders
More informationIncidence of Parasitic Dermatological Disorders in Dogs A Detailed Epidemiological Study
International Journal of Current Microbiology and Applied Sciences ISSN: 2319-7706 Volume 7 Number 09 (2018) Journal homepage: http://www.ijcmas.com Original Research Article https://doi.org/10.20546/ijcmas.2018.709.014
More informationDrug-induced panniculitis due to deworming in a dog case report
434 CASE REPORT Drug-induced panniculitis due to deworming in a dog case report Paniculite farmacodérmica decorrente de vermifugação em um cão - relato de caso Cayo Yuji NITTA 1,2 ; Solange Maria GENNARI
More informationNUMBER: /2005
Purpose PAGE 1 OF 7 The purpose of this policy is to describe the procedures for keeping and maintaining animal medical records. This procedure is approved by the Creighton University Institutional Animal
More informationDoug Carithers 1 William Russell Everett 2 Sheila Gross 3 Jordan Crawford 1
Comparative Efficacy of fipronil/(s)-methoprene-pyriproxyfen (FRONTLINE Gold) and Sarolaner (Simparica ) Against Induced Infestations of Ixodes scapularis on Dogs Doug Carithers 1 William Russell Everett
More informationOverview of C. difficile infections. Kurt B. Stevenson, MD MPH Professor Division of Infectious Diseases
Overview of C. difficile infections Kurt B. Stevenson, MD MPH Professor Division of Infectious Diseases Conflicts of Interest I have no financial conflicts of interest related to this topic and presentation.
More informationESSENTIALS OF ANTIMICROBIAL PHARMACOLOGY
ESSENTIALS OF ANTIMICROBIAL PHARMACOLOGY Essentials of Antimicrobial Pharmacology A Guide to Fundamentals for Practice PAUL H. AXELSEN, MD University of Pennsylvania School of Medicine Philadelphia, PA
More informationAnesthesia Check-off Form
Anesthesia Check-off Form 5231 SW 91st Drive Gainesville, FL 32608 (352) 377-6003 The doctors and staff at Haile Plantation Animal Clinic would like to offer the most advanced medical care and services
More informationDear Doctor: Our sincerest thanks, Stephen A. Connell, DVM Director, Technical, Academic and Consumer Services Elanco Companion Animal Health
Dear Doctor: As a trained professional, you understand the loss of a pet is incredibly difficult. Every pet owner responds differently as they grieve. We believe the recent negative media coverage of Trifexis
More informationAustralian and New Zealand College of Veterinary Scientists. Membership Examination. Small Animal Medicine Paper 1
Australian and New Zealand College of Veterinary Scientists Membership Examination June 2015 Small Animal Medicine Paper 1 Perusal time: Fifteen (15) minutes Time allowed: Two (2) hours after perusal Answer
More informationPharmacist Coordinated Antimicrobial Therapy: OPAT and Transitions of Care
Pharmacist Coordinated Antimicrobial Therapy: OPAT and Transitions of Care Jennifer McCann, PharmD, BCCCP State Director of Clinical Pharmacy Services St. Vincent Health Indiana Conflicts of Interest No
More informationEPSIPRANTEL Veterinary Oral-Local
EPSIPRANTEL Veterinary Oral-Local A commonly used brand name for a veterinary-labeled product is Cestex. Note: For a listing of dosage forms and brand names by country availability, see the Dosage Forms
More information